Lysozyme (LYZ) Mouse Monoclonal Antibody [Clone ID: OTI2C2]

CAT#: TA506197S

LYZ mouse monoclonal antibody, clone OTI2C2 (formerly 2C2)

Size: 30 ul 100 ul



  View other "OTI2C2" antibodies (4)

Need it in bulk or conjugated?
Get a free quote

【特别福利】购一抗正装产品,免费领10ul抗体试用装

CNY 800.00


货期*
现货

规格
    • 30 ul

Product images

经常一起买 (3)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Recombinant protein of human lysozyme (renal amyloidosis) (LYZ), 20 µg
    • 20 ug

CNY 2,900.00
CNY 6,650.00


Transient overexpression lysate of lysozyme (renal amyloidosis) (LYZ)
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Clone Name OTI2C2
Applications IF, WB
Recommend Dilution WB 1:4000, IF 1:100
Reactivity Human
Host Mouse
Clonality Monoclonal
Immunogen Full length human recombinant protein of human LYZ(NP_000230) produced in HEK293T cell.
Formulation PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Concentration 1 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Predicted Protein Size 14.7 kDa
Gene Name lysozyme
Background This gene encodes human lysozyme, whose natural substrate is the bacterial cell wall peptidoglycan (cleaving the beta[1-4]glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine). Lysozyme is one of the anti-microbial agents found in human milk, and is also present in spleen, lung, kidney, white blood cells, plasma, saliva, and tears. Missense mutations in LYZ have been identified in heritable renal amyloidosis. [provided by RefSeq, Jul 2008]
Synonyms LYZF1; LZM
Reference Data
Protein Families Druggable Genome
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...